Marge Josephson
Investitore di Private Equity presso Bay City Capital LLC
Provenienza dei contatti di primo grado di Marge Josephson
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Bay City Capital LLC
Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States.
34
| Private Company | Investment Managers | 34 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Marge Josephson tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Consultant / Advisor Corporate Officer/Principal | |
PONIARD PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member Chief Executive Officer | |
Epoch Biosciences, Inc.
Epoch Biosciences, Inc. Medical SpecialtiesHealth Technology Epoch Biosciences, Inc. manufactures and develops molecular tools for genetic analysis. Its technology has numerous applications including the detection of inherited diseases and single nucleotide polymorphisms to identify individuals at risk for disease or adverse drug reactions and gene expression measurement. The company was founded in 1985 and is headquartered in Bothell, WA. | Medical Specialties | Chairman Chief Executive Officer | |
ARROWHEAD PHARMACEUTICALS, INC. | Biotechnology | Chairman Director/Board Member | |
Reliant Pharmaceuticals LLC
Reliant Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ | Miscellaneous Commercial Services | Chairman Founder Director/Board Member | |
PTC THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Pathway Diagnostics Corp.
Pathway Diagnostics Corp. Medical SpecialtiesHealth Technology Pathway Diagnostics Corp. develops biomedical and biomarker products. It develops biomarkers of disease into novel esoteric tests. The company specializes in the identification, optimization & validation of biomarker assays for all phases of drug development and clinical diagnostic applications makes them a valuable partner for pharmaceutical & biotechnology companies. Pathway Diagnostics is headquartered in Malibu, CA. | Medical Specialties | Director/Board Member Chairman | |
HYPERION THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member | |
Vivaldi Biosciences, Inc.
Vivaldi Biosciences, Inc. Drugstore ChainsRetail Trade Vivaldi Biosciences Inc. develops and markets vaccines. It specializes in developing live attenuated influenza vaccines (LAIVs). The company was founded by Eliott Kieff, Peter Palese, and Adolfo García-Sastre in 2006 and is headquartered in Fort Collins, CO. | Drugstore Chains | Director/Board Member Director/Board Member | |
Nexus Dx, Inc.
Nexus Dx, Inc. Medical/Nursing ServicesHealth Services Nexus Dx, Inc. engages in the provision of of a near patient testing system and advanced diagnostic solution. Its offers point-of-care (POC) immunoassay, IB10 analyzer system, and tests for established critical care parameters. The company was founded on January 16, 2009 and is headquartered in San Diego, CA. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
Oracle Partners LP | Private Equity Investor Corporate Officer/Principal | ||
Stanford University | College/University | Doctorate Degree Masters Business Admin Doctorate Degree Undergraduate Degree | |
The University of Chicago | College/University | Doctorate Degree Director/Board Member | |
Princeton University | College/University | Undergraduate Degree Director/Board Member | |
INSEAD | College/University | Masters Business Admin Masters Business Admin | |
University of California, Berkeley | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
The University of California, San Francisco | College/University | Doctorate Degree Doctorate Degree | |
5AM Venture Management LLC
5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Investment Managers | Founder Founder | |
The Pritzker Organization LLC
The Pritzker Organization LLC Investment ManagersFinance The Pritzker Organization LLC (TPO) is a private equity subsidiary of PRITZKER FAMILY founded in 2002 by Tom Pritzker. The firm is headquartered in New York. | Investment Managers | Chief Executive Officer Corporate Officer/Principal | |
VIA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
NEVRO CORP. | Medical Specialties | Director/Board Member Founder | |
EPIZYME, INC. | Biotechnology | Director/Board Member Director/Board Member | |
SynGen, Inc.
SynGen, Inc. Electronic Equipment/InstrumentsElectronic Technology SynGen, Inc. designs and manufactures innovative devices designed for separation and isolation of therapeutic cells. It offers products that improve the recovery, purity and viability of stem and other clinically important cells from umbilical cord blood, peripheral blood, bone marrow, and cell culture. The firms products include SynGenX-1000 System, CryoPRO-2 Bag Sets, SynGenX-LAB System, and tube welding workstation. The company was founded by Philip H. Coelho, Gabriel G. Alvarado, and George J. Barry in 1999 and is headquartered in Rancho Cordova, CA | Electronic Equipment/Instruments | Director/Board Member Chief Executive Officer | |
Synchronicity Pharma, Inc.
Synchronicity Pharma, Inc. Pharmaceuticals: OtherHealth Technology Synchronicity Pharma, Inc. discovers, develops and commercializes novel therapeutics. Its products identify components of the circadian system that can be targeted to treat metabolic and related disorders, such as diabetes, obesity, and cardiovascular diseases. The company was founded by Ross S. Bersot, Joseph S. Takahashi, Masashi Yanagisawas and Ron Evans in 2008 and is headquartered in San Jose, CA. | Pharmaceuticals: Other | Director/Board Member Chief Executive Officer | |
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
The University of Chicago Booth School of Business | College/University | Masters Business Admin | |
Tallikut Pharmaceuticals, Inc. | Director/Board Member Director/Board Member | ||
Entasis Therapeutics, Inc.
Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member | |
Shenzhen GeneMDx Biotech Co., Ltd.
Shenzhen GeneMDx Biotech Co., Ltd. BiotechnologyHealth Technology Shenzhen GeneMDx Biotech Co., Ltd. manufactures biologique products. It engages in domestic sales of medical equipments and diagnosis reagents. The company was founded on June 23, 2011 and is headquartered in Shenzhen, China. | Biotechnology | Director/Board Member Director/Board Member | |
MADRIGAL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
Oculis SA
Oculis SA Miscellaneous Commercial ServicesCommercial Services Oculis SA focuses on ophthalmic drugs and novel drug delivery to the eye. The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME (diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. The company was founded by Einar Stefansson and Thorsteinn Loftsson in 2003is headquartered in Pully, Switzerland. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Bay City Capital GF Xinde Intl Life Sciences USD Fund LP
Bay City Capital GF Xinde Intl Life Sciences USD Fund LP Investment ManagersFinance Bay City Capital GF Xinde International Life Sciences USD Fund LP invests in companies located United States, Canada, Western Europe and China. The Fund targets companies operating in the fields of life sciences. It provides financing for seed, early and later stage capital requirements. | Investment Managers | Director/Board Member Director/Board Member | |
EpimAb Biotherapeutics, Inc.
EpimAb Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology EpimAb Biotherapeutics, Inc. is a Chinese clinical stage biopharmaceutical company that specializes in developing multispecific antibodies. The company is based in Shanghai, China. The company utilizes its in-house research and technology capabilities, including the proprietary fit-ig® and mat-fab bispecific platforms, to generate and advance a unique pipeline of transformative preclinical and clinical assets that aim to benefit cancer patients. The company was founded in 2016 by Chen Bing Wu, who has been the CEO since 2016. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Imidomics, Inc.
Imidomics, Inc. BiotechnologyHealth Technology Imidomics, Inc. is an American biotechnology company that focuses on discovering and developing new medicines for immune-mediated inflammatory diseases (IMIDs). The company is based in an undisclosed location. Imidomics has access to the IMID-biobank, which includes real-world data from clinical records and biological samples from over 17,000 IMID patients and control subjects across six indications. The company utilizes a proprietary digital bioinformatics portal called the Imidomics Precision Discovery Platform to generate novel insights into disease mechanisms and identify potential new drug targets. The company was founded in Barcelona in 2015 by Dr. Sara Marsal and Dr. Richard M. Myers. The CEO of the company is Fred Bernard Craves. | Biotechnology | Chief Executive Officer Chief Operating Officer Director of Finance/CFO | |
ENTASIS THERAPEUTICS HOLDINGS INC. | Biotechnology | Director/Board Member | |
RALLYBIO CORPORATION | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 46 |
Cina | 3 |
Francia | 2 |
Svizzera | 2 |
Isole Cayman | 2 |
Settori
Health Technology | 27 |
Consumer Services | 8 |
Commercial Services | 5 |
Finance | 5 |
Health Services | 4 |
Posizioni
Director/Board Member | 320 |
Corporate Officer/Principal | 93 |
Independent Dir/Board Member | 55 |
Chairman | 40 |
Private Equity Investor | 35 |
Contatti più connessi
Insiders | |
---|---|
Nina Kjellson | 49 |
Andrew Schwab | 45 |
Fred Craves | 36 |
Douglass Given | 35 |
Carl Goldfischer | 31 |
Xiang Ming Cui | 31 |
John Diekman | 29 |
Michael Perry | 28 |
Lionel Carnot | 27 |
Thomas Pritzker | 23 |
William G. Gerber | 22 |
Robert Hopfner | 20 |
Victor Tong | 20 |
Jeanne Cunicelli | 19 |
Bill Burkoth | 19 |
- Borsa valori
- Insiders
- Marge Josephson
- Connessioni Società